These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 25000562)
1. Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? Ciucci A; Meco D; De Stefano I; Travaglia D; Zannoni GF; Scambia G; Riccardi R; Saran A; Mancuso M; Gallo D PLoS One; 2014; 9(7):e101623. PubMed ID: 25000562 [TBL] [Abstract][Full Text] [Related]
2. The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways. Mancuso M; Leonardi S; Giardullo P; Pasquali E; Borra F; Stefano ID; Prisco MG; Tanori M; Scambia G; Majo VD; Pazzaglia S; Saran A; Gallo D Cancer Lett; 2011 Sep; 308(2):197-202. PubMed ID: 21636213 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammary tumor growth by estrogens: is there a specific role for estrogen receptors alpha and beta? Soldati R; Wargon V; Cerliani JP; Giulianelli S; Vanzulli SI; Gorostiaga MA; Bolado J; do Campo P; Molinolo A; Vollmer G; Lanari C Breast Cancer Res Treat; 2010 Oct; 123(3):709-24. PubMed ID: 20012353 [TBL] [Abstract][Full Text] [Related]
4. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma. Belcher SM; Ma X; Le HH Endocrinology; 2009 Mar; 150(3):1112-21. PubMed ID: 19008315 [TBL] [Abstract][Full Text] [Related]
5. Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma. Cookman CJ; Belcher SM Endocrinology; 2015 Jul; 156(7):2395-408. PubMed ID: 25885794 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists. Krom YD; Pires NM; Jukema JW; de Vries MR; Frants RR; Havekes LM; van Dijk KW; Quax PH Cardiovasc Res; 2007 Jan; 73(1):217-26. PubMed ID: 17141206 [TBL] [Abstract][Full Text] [Related]
7. Estradiol and testosterone regulate arginine-vasopressin expression in SH-SY5Y human female neuroblastoma cells through estrogen receptors-α and -β. Grassi D; Bellini MJ; Acaz-Fonseca E; Panzica G; Garcia-Segura LM Endocrinology; 2013 Jun; 154(6):2092-100. PubMed ID: 23584859 [TBL] [Abstract][Full Text] [Related]
8. Sex specific response of cultured human bone cells to ERα and ERβ specific agonists by modulation of cell proliferation and creatine kinase specific activity. Somjen D; Katzburg S; Sharon O; Knoll E; Hendel D; Stern N J Steroid Biochem Mol Biol; 2011 Jul; 125(3-5):226-30. PubMed ID: 21397017 [TBL] [Abstract][Full Text] [Related]
9. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Yi KW; Shin JH; Seo HS; Lee JK; Oh MJ; Kim T; Saw HS; Kim SH; Hur JY Obesity (Silver Spring); 2008 Nov; 16(11):2393-9. PubMed ID: 18719660 [TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells. Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healing. Peržeľová V; Sabol F; Vasilenko T; Novotný M; Kováč I; Slezák M; Ďurkáč J; Hollý M; Pilátová M; Szabo P; Varinská L; Čriepoková Z; Kučera T; Kaltner H; André S; Gabius HJ; Mučaji P; Smetana K; Gál P Int J Mol Med; 2016 Jan; 37(1):21-8. PubMed ID: 26397183 [TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3. Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935 [TBL] [Abstract][Full Text] [Related]
14. High dose 17 beta-estradiol and the alpha-estrogen agonist PPT trigger apoptosis in human adrenal carcinoma cells but the beta-estrogen agonist DPN does not. Prieto LM; Brown JW; Perez-Stable C; Fishman LM Horm Metab Res; 2008 May; 40(5):311-4. PubMed ID: 18491249 [TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta (ERbeta) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells. Hershberger PA; Stabile LP; Kanterewicz B; Rothstein ME; Gubish CT; Land S; Shuai Y; Siegfried JM; Nichols M J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):102-9. PubMed ID: 19460433 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor-mediated enhancement of venous relaxation in female rat: implications in sex-related differences in varicose veins. Raffetto JD; Qiao X; Beauregard KG; Khalil RA J Vasc Surg; 2010 Apr; 51(4):972-81. PubMed ID: 20347696 [TBL] [Abstract][Full Text] [Related]
17. Acute postischemic treatment with estrogen receptor-alpha agonist or estrogen receptor-beta agonist improves myocardial recovery. Vornehm ND; Wang M; Abarbanell A; Herrmann J; Weil B; Tan J; Wang Y; Kelly M; Meldrum DR Surgery; 2009 Aug; 146(2):145-54. PubMed ID: 19628068 [TBL] [Abstract][Full Text] [Related]
18. Dilatory responses to estrogenic compounds in small femoral arteries of male and female estrogen receptor-beta knockout mice. Cruz MN; Douglas G; Gustafsson JA; Poston L; Kublickiene K Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H823-9. PubMed ID: 16183727 [TBL] [Abstract][Full Text] [Related]
19. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line. Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084 [TBL] [Abstract][Full Text] [Related]
20. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Teng J; Wang ZY; Jarrard DF; Bjorling DE Endocr Relat Cancer; 2008 Mar; 15(1):351-64. PubMed ID: 18310301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]